期刊
ANNALS OF TRANSLATIONAL MEDICINE
卷 7, 期 23, 页码 -出版社
AME PUBL CO
DOI: 10.21037/atm.2019.11.102
关键词
Vitamin D (VD); acute graft-versus-host disease (aGVHD); regulatory T cell (Treg); forkhead box P3 (Foxp3)
资金
- National Natural Science Fund Outstanding Youth Fund [81522020]
- 863 Young Scientists Special Fund [2015AA020932]
- National Natural Science Fund in China [91442117, 81571564]
- foundation of Jiangsu Collaborative Innovation Center of Biomedical Functional materials
- Priority Academic Program Development of Jiangsu Higher Education Institutions
Background: Acute graft-versus-host disease (aGVHD) is a medical complication which may result in significant morbidity and mortality after transplantation. The aim of this study investigated the therapeutic effect and underlying mechanism of 1,25-dihydroxyvitamin D3 (1 alpha,25(OH)(2)D-3) in the treatment of aGVHD. Method: An aGVHD model was built by transferring splenocytes of B6 mice into B6D2F1 mice. 1 alpha,25(OH)(2)D-3 was added to evaluate the protective function to aGVHD; the phenotype and cytokine expression profile of spleen cells from the aGVHD model were determined using flow cytometry 2 weeks after the model is established. Result: Administration of 1 alpha,25(OH)(2)D-3 significantly slowed aGVHD progression and improved survival of B6D2F1 recipients of grafted B6 splenocytes. 1 alpha, 25(OH)(2)D-3 treatment also resulted in an increased number of CD4(+)Foxp3(+) regulatory T cells (Tregs) but decreased the number of CD4(+)IL-4(+) cells. In vitro analysis demonstrated that 1 alpha,25(OH)(2)D-3 directly increased forkhead box P3 (Foxp3) and IL-10 expression and enhanced the function of induced Tregs (iTregs). Conclusions: This analysis indicated that the effect of 1 alpha,25(OH)(2)D-3 is mediated in part by improving the number of Tregs. 1 alpha,25(OH)(2)D-3 administration thus represents a viable approach for treating aGVHD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据